← Back
$OCUL All transactions

OCULAR THERAPEUTIX, INC

A

$ Value

$0

Shares

122,923

Price

$0

Filed

Aug 14

Insider

Name

Waheed Nadia

Title

Chief Medical Officer

CIK

0002023884

Roles

Officer

Transaction Details

Transaction Date

2025-08-12

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

122,923

Footnotes

On August 12, 2025, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Corporation"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, in equal annual installments, beginning on February 11, 2026. | 7/48 of the shares underlying the option vest on September 11, 2025, and 1/48 of the shares underlying the option vest monthly thereafter through February 11, 2029.

Filing Info

Accession No.

0001104659-25-078783

Form Type

4

Issuer CIK

0001393434

Waheed Nadia's History

Date Ticker Type Value
2026-02-20 OCUL $27K
2026-02-12 OCUL $71K
2026-01-02 OCUL A $0
2026-01-02 OCUL A $0
2025-08-12 OCUL A $0
2025-08-12 OCUL A $0
2025-06-02 OCUL $112K

Other Insiders at OCUL (90d)

Insider Bought Sold Last
LINDSTROM RICHARD L MD $461K 2026-02-20
Heier Jeffrey S.
Chief Scientific Officer
$25K 2026-02-23
Dugel Pravin
See Remarks
$1.3M 2026-04-09
Notman Donald
Chief Operating Officer
$205K 2026-02-12
Kaiser Peter
Chief Development Officer
$23K 2026-02-23
Nayak Sanjay
Chief Strategy Officer
$108K 2026-02-23
Waheed Nadia
Chief Medical Officer
$98K 2026-02-20
Robinson David Wayne
Global CCO
2026-01-21